Clinical Trial Update: Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a once-daily dexlansoprazole-based quadruple therapy for Helicobacter pylori eradication has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Dexilant (dexlansoprazole)

Snippet

Sponsor: Ramathibodi Hospital | Conditions: H Pylori Eradication | Phase 4 | Status: COMPLETED